Aavogen
Rockville
About Aavogen
Aavogen is a biotech startup that develops gene therapeutics for muscle wasting diseases. This includes muscular dystrophy, inflammatory myopathies and heart failure. We make you stronger.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Funding stage: Seed
- Last round: Grant (Sep 2025)
- Website: aavogen.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/aavogen-21195 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.